Heron Patrick J
CIK 1365617
Transactions on file
26
Open-market buys
20
Win rate (buys)
100%
20 scored
Avg % since filing (buys)
+136.3%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | 2026-06-05 | ARQT Arcutis Biotherapeutics, Inc. | Director | Grant | 5,778 | $0.00 | — | open → |
| 2025-03-06 | 2025-03-04 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 56 | $2.6K | +145.0% | open → |
| 2025-03-06 | 2025-03-05 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 267 | $11.9K | +152.7% | open → |
| 2025-03-06 | 2025-03-04 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 1,279 | $58.3K | +147.2% | open → |
| 2025-03-10 | 2025-03-07 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 580 | $25.1K | +160.6% | open → |
| 2025-03-10 | 2025-03-06 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 1,335 | $58.6K | +156.5% | open → |
| 2025-03-12 | 2025-03-10 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 758 | $32.3K | +163.9% | open → |
| 2025-03-12 | 2025-03-10 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 577 | $25.0K | +159.6% | open → |
| 2025-03-12 | 2025-03-11 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 963 | $42.2K | +157.2% | open → |
| 2025-03-18 | 2025-03-14 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 528 | $23.3K | +155.2% | open → |
| 2025-03-18 | 2025-03-17 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 21 | $922.53 | +156.3% | open → |
| 2025-05-13 | 2025-05-09 | ARQT Arcutis Biotherapeutics, Inc. | Director | Buy | 6,300 | $85.7K | +105.8% | open → |
| 2025-05-15 | 2025-05-13 | ARQT Arcutis Biotherapeutics, Inc. | Director | Buy | 2,374 | $32.7K | +103.4% | open → |
| 2025-05-15 | 2025-05-14 | ARQT Arcutis Biotherapeutics, Inc. | Director | Buy | 6,300 | $86.7K | +103.4% | open → |
| 2025-05-19 | 2025-05-15 | ARQT Arcutis Biotherapeutics, Inc. | Director | Buy | 2,520 | $34.3K | +105.5% | open → |
| 2025-05-23 | 2025-05-22 | ARQT Arcutis Biotherapeutics, Inc. | Director | Buy | 2,520 | $34.4K | +105.1% | open → |
| 2025-05-23 | 2025-05-21 | ARQT Arcutis Biotherapeutics, Inc. | Director | Buy | 2,520 | $34.4K | +104.9% | open → |
| 2025-06-02 | 2025-05-29 | MIRM Mirum Pharmaceuticals, Inc. | Director | Exer. | 5,703 | — | — | open → |
| 2025-06-06 | 2025-06-04 | ARQT Arcutis Biotherapeutics, Inc. | Director | Buy | 1,890 | $25.2K | +110.1% | open → |
| 2025-06-06 | 2025-06-05 | ARQT Arcutis Biotherapeutics, Inc. | Director | Buy | 378 | $5.1K | +108.7% | open → |
| 2025-06-16 | 2025-06-12 | ARQT Arcutis Biotherapeutics, Inc. | Director10% | Grant | 7,609 | $0.00 | — | open → |
| 2025-06-17 | 2025-06-13 | ARQT Arcutis Biotherapeutics, Inc. | Director | Buy | 2,646 | $34.6K | +114.0% | open → |
| 2025-06-25 | 2025-06-23 | HLVX HilleVax, Inc. | Director | Grant | 17,199 | $0.00 | — | open → |
| 2025-09-17 | 2025-09-17 | HLVX HilleVax, Inc. | Director10% | U | 17,199 | $33.5K | — | open → |
| 2025-09-17 | 2025-09-17 | HLVX HilleVax, Inc. | Director10% | U | 8,535,337 | $16.64M | — | open → |
| 2025-09-30 | 2025-09-26 | MBX MBX Biosciences, Inc. | Director10% | Buy | 666,666 | $12.00M | +210.7% | open → |
